Quick View
| Metric | Current Period | Same Period of Previous Year | YoY |
|---|---|---|---|
| Revenue | - | - | - |
| Operating Income | −¥6.0B | −¥4.7B | −28.2% |
| Ordinary Income | −¥5.7B | −¥4.8B | −18.6% |
| Net Income | −¥5.7B | −¥4.8B | −18.3% |
| ROE (Annualized) | −47.8% | −32.6% | - |
Executive Summary
As a research and development-driven company, the Company remains in a loss-making phase accompanied by cash consumption, with the loss widening from the same period of the previous year. Operating loss was 6.00B, widening 28.2% from 4.68B in the same period of the previous year; ordinary loss was 5.68B, widening 18.6% year on year; and net income was a loss of 5.68B, widening 18.3% year on year (net income refers to consolidated net income). The fact that ordinary loss widened only marginally less than operating loss was because non-operating income, including a foreign exchange gain of 0.30B, partially offset the loss; this does not indicate an improvement in the underlying earnings power of the business.
Factors Driving Changes in Performance
【Revenue】Revenue was not disclosed in this financial results announcement, reflecting the business structure being in the research and development investment phase.
【Profit and Loss】Operating loss was 6.00B, widening 28.2% year on year and representing the primary factor behind the deterioration in earnings. Ordinary loss was limited to 5.68B, as non-operating income of 0.32B, including a foreign exchange gain of 0.30B and interest income of 0.02B, partially mitigated the operating loss. Against a loss before income taxes of 5.68B, income taxes and other taxes amounted to only 0.01B, resulting in a net loss of 5.68B. The structure is driven by the widening of losses at the operating level, leading to the conclusion of lower revenue and lower earnings (more precisely, widening losses in the absence of revenue).
Key Financial Indicators
【Profitability】Operating loss of 6.00B, ordinary loss of 5.68B, and net loss of 5.68B all deteriorated from the same period of the previous year, while ROE (annualized) was extremely low at -47.8%. The equity ratio was high at 96.1%, reflecting limited use of debt, but this does not offset the low profitability.【Cash Flow Quality】Operating Cash Flow (OCF) was -6.53B, representing a cash outflow exceeding the net loss of 5.68B; the fact that OCF was a greater outflow than net loss indicates movement in the opposite direction from the conversion of earnings into cash.【Investment Efficiency】The loss burden relative to invested capital was substantial, and the Company remains in a phase in which development investment has not yet been monetized.【Financial Soundness】Liquidity was extremely ample, with current assets of 23.77B against current liabilities of 0.96B, and the debt-to-equity ratio remained low; however, retained earnings reflected accumulated losses of -145.80B, and net assets declined 19.3% from 29.43B in the same period of the previous year to 23.76B.
Cash Flow Analysis
Operating Cash Flow (OCF) was -6.53B, deteriorating by 4.83B from -1.71B in the same period of the previous year, indicating an accelerated pace of cash outflows. OCF represented an outflow 0.85B greater than the net loss of 5.68B, with an increase in advances paid of 0.64B being one factor tying up funds. No financing through financing cash flow was observed during the period, and cash and deposits decreased by 6.26B from 28.28B at the end of the same period of the previous year to 22.02B. As a result, the primary movement of funds consisted of outflows from operating activities, and the period-end cash balance is at a point where the future pace of cash consumption requires close monitoring.
Earnings Quality
Ordinary loss of 5.68B resulted from non-operating income of 0.32B, primarily consisting of a foreign exchange gain of 0.30B, partially offsetting the operating loss of 6.00B; this improvement should be distinguished from the business’s sustainable earnings power as a temporary factor. Income taxes and other taxes remained at 0.01B, resulting in a net loss nearly equal to the loss before income taxes. While OCF represented an outflow exceeding net loss, the accrual ratio remained low, indicating limited signs that the recognition of losses was significantly distorted by non-cash accruals. Overall, the reduction in losses at the ordinary income level depended on the non-recurring factor of foreign exchange, and operating loss trends should be prioritized when assessing earnings quality.
Shareholder Returns
Both the Q2 dividend and the full-year dividend forecast were ¥0 per share, with no revision to the dividend forecast during the quarter. As no dividends were paid, the payout ratio was effectively 0%. With cash outflows continuing, including OCF of -6.53B and a net loss of 5.68B, internal funds, including cash and deposits of 22.02B, are in a situation where priority is being given to business continuity and allocation to development investment.
Risk Factors
-
Development Progress Risk: As a research and development-driven business, delays in clinical development, trial results, and uncertainty regarding obtaining approvals will affect the timing of monetization. Operating loss has widened 28.2% year on year, and losses may continue until development investment translates into business value.
-
Cash Consumption Risk: OCF was -6.53B, deteriorating from -1.71B in the same period of the previous year. Cash and deposits decreased by 6.26B (22.0%) from the end of the same period of the previous year, and continued cash consumption at the current pace could increase dependence on future financing.
-
Capital Policy Risk: Retained earnings reflect accumulated losses of -145.80B, while net assets decreased 19.3% year on year. If ongoing losses place further pressure on net assets, flexibility in capital policy may decline. Meanwhile, short-term financial soundness remains high, with a debt-to-equity ratio of 0.04x and a current ratio of 2,466.3%.
Industry Benchmark (For Reference; Compiled by the Company)
No industry benchmark data available
※Source: Compiled by the Company
Key Takeaways from the Financial Results
-
Operating loss of 6.00B and net loss of 5.68B both widened from the same period of the previous year, confirming a trend of continued losses during the development investment phase.
-
OCF was -6.53B, representing a cash outflow exceeding net loss, and cash and deposits declined to 22.02B. The future pace of cash consumption will be a structural focal point affecting the Company’s ability to continue development activities.
-
The conservative capital structure, with a current ratio of 2,466.3% and a debt-to-equity ratio of 0.04x, indicates short-term financial resilience, while the no-dividend policy is consistent with the retention of internal funds during a period of cash outflows.
This report is an earnings analysis document automatically generated by AI based on XBRL financial results announcement data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly available financial results data. Investment decisions should be made at your own responsibility, after consulting professionals as necessary.
---End of Report---